Q5128 Medicaid Rate by State

Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

30 state Medicaid programs publish a fee-for-service rate for Q5128 (injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg), ranging from $40.00 in New Hampshire to $385.60 in Indiana among rates on the same basis.

Every state, kept current

Every code in every state: the Rates plan

$29 /mo, 7-day free trial

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: State-Specific Services across 45 states, 1,475 codes.

2026-11-19 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

30

Median % of Medicare

--

Rate range, like rates

$40.00 - $385.60

Q5128 rates in every publishing state

  • Alabama$86.16

    2026

  • Arkansas$310.08

    2026

  • Arizona$160.30

    surgery center payment

    2026

  • California$83.48

    2026

  • Connecticut$83.34

    2026

  • District of Columbia$83.34

    Prior auth: required, 2026

  • Iowa$275.48

    2024

  • Idaho$72.01

    Prior auth: not required, 2026

  • Illinois$81.22

    2026

  • Indiana$385.60

    2023

  • Kansas$82.53

    2026

  • Kentucky$83.34

    surgery center payment

    2026

  • Michigan$82.53

    2026

  • Minnesota$83.47

    Prior auth: required, 2026

  • Mississippi$83.48

    2026

  • Montana$83.34

    2026

  • Nebraska$42.72

    2026

  • New Hampshire$40.00

    Prior auth: not required, 2026

  • New Jersey$269.28

    Prior auth: not required, 2026

  • New Mexico$168.74

    2025

  • Oklahoma$81.13

    2026

  • Rhode Island$308.39

    hospital outpatient payment

    2026

  • South Carolina$81.13

    2026

  • Texas$86.51

    2026

  • Utah$82.53

    Prior auth: not required, 2026

  • Virginia$83.47

    ages 18 and up

    2026

  • Vermont$81.85

    2026

  • Washington$83.48

    2026

  • Wisconsin$82.53

    2026

  • Wyoming$82.53

    2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related state-specific services codes

All 56 codes from Q5098 to Q5167 or every state-specific services code by number.

Frequently asked questions

How much does Medicaid pay for Q5128?

30 state Medicaid programs publish a fee-for-service rate for Q5128 (injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg), ranging from $40.00 in New Hampshire to $385.60 in Indiana among rates on the same basis. The full table on this page lists every publishing state's current rate.

Which state pays the most for Q5128?

Indiana publishes the highest Medicaid rate for Q5128 at $385.60. New Hampshire publishes the lowest at $40.00, among rates on the same basis; rentals and rates far from the other states' are in the table with their basis.

Does Q5128 require prior authorization under Medicaid?

2 of the 30 publishing states flag Q5128 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".